Histone Methyltransferases G9a/
Ewing sarcoma
G9a
GLP
histone methyltransferase
neuroblastoma
pediatric cancer
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
17 Oct 2023
17 Oct 2023
Historique:
received:
01
09
2023
revised:
07
10
2023
accepted:
10
10
2023
medline:
30
10
2023
pubmed:
28
10
2023
entrez:
28
10
2023
Statut:
epublish
Résumé
Changes in epigenetic programming have been proposed as being key events in the initiation and progression of childhood cancers. HMT euchromatic histone lysine methyltransferase 2 (G9a, EHMT2), which is encoded by the
Identifiants
pubmed: 37894922
pii: ijms242015242
doi: 10.3390/ijms242015242
pmc: PMC10607632
pii:
doi:
Substances chimiques
EHMT2 protein, human
EC 2.1.1.43
Histocompatibility Antigens
0
Histone Methyltransferases
EC 2.1.1.-
Histone-Lysine N-Methyltransferase
EC 2.1.1.43
EHMT1 protein, human
EC 2.1.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : N/A
Pays : United States
Références
Mol Neurobiol. 2017 Dec;54(10):7610-7619
pubmed: 27832522
Biochem J. 1993 Mar 15;290 ( Pt 3):811-8
pubmed: 8457211
JCI Insight. 2019 May 16;5:
pubmed: 31095524
Cell Rep. 2016 Apr 5;15(1):77-85
pubmed: 27052169
Front Oncol. 2020 May 27;10:818
pubmed: 32537432
Cancer Cell. 2003 Jan;3(1):89-95
pubmed: 12559178
Clin Cancer Res. 2021 Apr 15;27(8):2179-2189
pubmed: 33504555
PLoS One. 2014 Sep 08;9(9):e106962
pubmed: 25198515
Nature. 2015 Oct 29;526(7575):700-4
pubmed: 26466568
Genes Dev. 2005 Apr 1;19(7):815-26
pubmed: 15774718
Cancer Res. 2010 Oct 15;70(20):7830-40
pubmed: 20940408
Science. 1984 Jun 8;224(4653):1121-4
pubmed: 6719137
Cancer Cell. 2014 Nov 10;26(5):668-681
pubmed: 25453903
Clin Epigenetics. 2016 May 24;8:57
pubmed: 27222667
Nat Genet. 2013 Mar;45(3):279-84
pubmed: 23334666
Elife. 2018 May 10;7:
pubmed: 29745895
Curr Biol. 2003 Jul 15;13(14):1192-200
pubmed: 12867029
Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28355
pubmed: 33818887
Oncogene. 2007 Jan 4;26(1):77-90
pubmed: 16799634
Genes Dev. 2012 Nov 15;26(22):2499-511
pubmed: 23105005
J Clin Oncol. 2015 Sep 20;33(27):3008-17
pubmed: 26304901
Mamm Genome. 2001 Dec;12(12):916-24
pubmed: 11707778
Mol Cell. 2022 Dec 15;82(24):4611-4626.e7
pubmed: 36476474
J Biol Chem. 2021 Nov;297(5):101276
pubmed: 34619147
Nat Genet. 2012 Nov;44(11):1199-206
pubmed: 23042116
Onco Targets Ther. 2018 Oct 15;11:6947-6956
pubmed: 30410352
J Med Chem. 2013 Nov 14;56(21):8931-42
pubmed: 24102134
Neuromolecular Med. 2022 Dec;24(4):392-398
pubmed: 35113321
Epigenetics Chromatin. 2022 Nov 21;15(1):36
pubmed: 36411491
Nat Rev Dis Primers. 2018 Jul 5;4(1):5
pubmed: 29977059
J Clin Oncol. 2009 May 1;27(13):2209-16
pubmed: 19307502
ISRN Oncol. 2011;2011:168712
pubmed: 22084725
Am J Respir Cell Mol Biol. 2018 Apr;58(4):449-460
pubmed: 29053336
Clin Cancer Res. 2012 May 15;18(10):2768-79
pubmed: 22589485
Mol Neurobiol. 2018 Sep;55(9):7242-7258
pubmed: 29397557
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1307-16
pubmed: 25737553
Int J Mol Sci. 2021 Oct 19;22(20):
pubmed: 34681949
Cancer Cell. 2017 Jan 9;31(1):50-63
pubmed: 28073004
N Engl J Med. 2021 Jan 14;384(2):154-164
pubmed: 33497548
Biochem Biophys Res Commun. 2020 Mar 26;524(1):57-63
pubmed: 31980180
Oncogene. 2022 Apr;41(18):2638-2650
pubmed: 35354905
Anticancer Drugs. 2013 Jun;24(5):484-93
pubmed: 23466651
Front Immunol. 2015 Sep 25;6:487
pubmed: 26441991